Matthias Cavassini
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
von Wyl V, Günthard H, Ledergerber B, Rickenbach M, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, Swiss HIV Cohort Study. Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309.
Apr 15, 2008Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
Apr 15, 2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Rickenbach Martin, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Simcock M, Rauch A, Swiss HIV Cohort Study. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy 2008; 13:1077-82.
Jan 1, 2008Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Jan 1, 2008Antiviral therapy 2008; 13:1077-82
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Simcock Mathew, Rauch Andri, Swiss HIV Cohort Study
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Wolbers M, Bucher H, Günthard H, Yerly S, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Hirschel B, von Wyl V, Opravil M, Swiss HIV Cohort Study. Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. AIDS (London, England) 2007; 21:2201-7.
Oct 18, 2007Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Oct 18, 2007AIDS (London, England) 2007; 21:2201-7
Wolbers Marcel, Bucher Heiner C, Günthard Huldrych, Yerly Sabine, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, von Wyl Viktor, Opravil Milos, Swiss HIV Cohort Study
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
Ledergerber B, Weber R, Egger M, Schmid P, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Lehmann R, Rickenbach M, Furrer H, Swiss HIV Cohort Study. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9.
Jul 1, 2007Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
Jul 1, 2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9
Ledergerber Bruno, Weber Rainer, Egger Matthias, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Elzi Luigia, Lehmann Roger, Rickenbach Martin, Furrer Hansjakob, Swiss HIV Cohort Study
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, Swiss HIV Cohort Study. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. HIV clinical trials 2007; 8:77-85.
Mar 1, 2007Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Mar 1, 2007HIV clinical trials 2007; 8:77-85
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, Swiss HIV Cohort Study
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
Wolbers M, Bucher H, Kaufmann G, Bernasconi E, Vernazza P, Hasse B, Cavassini M, Furrer H, Hirschel B, Battegay M, Swiss HIV Cohort Study. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral therapy 2007; 12:889-97.
Jan 1, 2007CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
Jan 1, 2007Antiviral therapy 2007; 12:889-97
Wolbers Marcel, Bucher Heiner C, Kaufmann Gilbert, Bernasconi Enos, Vernazza Pietro, Hasse Barbara, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Swiss HIV Cohort Study
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Wolbers M, Simcock M, Swiss HIV Cohort Study. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antiviral therapy 2007; 12:1165-73.
Jan 1, 2007Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
Jan 1, 2007Antiviral therapy 2007; 12:1165-73
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Wolbers Marcel, Simcock Mathew, Swiss HIV Cohort Study
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Wunder D, Furrer H, Mueller B, Bernasconi E, Schmid P, Elzi L, Cavassini M, Hirschel B, Mueller N, Fux C, Bersinger N, Swiss HIV Cohort Study. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antiviral therapy 2007; 12:261-5.
Jan 1, 2007Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Jan 1, 2007Antiviral therapy 2007; 12:261-5
Wunder Dorothea M, Furrer Hansjakob, Mueller Bruno, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Mueller Nicolas J, Fux Christoph A, Bersinger Nick A, Swiss HIV Cohort Study
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Elzi L, Furrer H, Rickenbach M, Bernasconi E, Schmid P, Cavassini M, Hirschel B, Weber R, Schlegel M, Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 44:94-102.
Jan 1, 2007Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Jan 1, 2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 44:94-102
Elzi Luigia, Furrer Hansjakob, Rickenbach Martin, Bernasconi Enos, Schmid Patrick, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Schlegel Matthias, Swiss HIV Cohort Study
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
Ananworanich J, Leduc D, Satchell C, Yerly S, Perrin L, Hill A, Perneger T, Phanuphak P, Furrer H, Cooper D, Ruxrungtham K, Hirschel B, Staccato Study Group, Bernasconi E, Vernazza P, Nüesch R, Gayet-Ageron A, Le Braz M, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Sirivichayakul S, Cavassini M, Karrer U, Genné D, Swiss HIV Cohort Study. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet 2006; 368:459-65.
Aug 5, 2006CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
Aug 5, 2006Lancet 2006; 368:459-65
Ananworanich Jintanat, Leduc Dominic, Satchell Claudette, Yerly Sabine, Perrin Luc, Hill Andrew, Perneger Thomas, Phanuphak Praphan, Furrer Hansjakob, Cooper David, Ruxrungtham Kiat, Hirschel Bernard, Staccato Study Group, Bernasconi Enos, Vernazza Pietro, Nüesch Reto, Gayet-Ageron Angèle, Le Braz Michelle, Prasithsirikul Wisit, Chetchotisakd Ploenchan, Kiertiburanakul Sasisopin, Munsakul Warangkana, Raksakulkarn Phitsanu, Tansuphasawasdikul Somboon, Sirivichayakul Sunee, Cavassini Matthias, Karrer Urs, Genné Daniel, Swiss HIV Cohort Study
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study
Glass T, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, De Geest S, Bucher H. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2006; 41:385-92.
Mar 1, 2006Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study
Mar 1, 2006Journal of acquired immune deficiency syndromes (1999) 2006; 41:385-92
Glass Tracy R, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, De Geest Sabina, Bucher Heiner C
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Karrer U, Speck R, Weber R, Russotti M, Schmid P, Hirschel B, Gayet-Ageron A, Cavassini M, Battegay M, Elzi L, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir. AIDS (London, England) 2005; 19:1987-94.
Nov 18, 2005Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Nov 18, 2005AIDS (London, England) 2005; 19:1987-94
Karrer Urs, Speck Roberto F, Weber Rainer, Russotti Marina, Schmid Patrick, Hirschel Bernard, Gayet-Ageron Angèle, Cavassini Matthias, Battegay Manuel, Elzi Luigia, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy
Wunder D, Furrer H, Schmid P, Schiffer V, Bucher H, Cavassini M, Bernasconi E, Weber R, Fux C, Bersinger N, Swiss HIV Cohort Study. Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS (London, England) 2005; 19:1837-42.
Nov 4, 2005Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy
Nov 4, 2005AIDS (London, England) 2005; 19:1837-42
Wunder Dorothea, Furrer Hansjakob, Schmid Patrick, Schiffer Véronique, Bucher Heiner C, Cavassini Matthias, Bernasconi Enos, Weber Rainer, Fux Christoph, Bersinger Nick A, Swiss HIV Cohort Study
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Perrin L, Ledergerber B, Furrer H, Swiss HIV Cohort Study. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:361-72.
Aug 1, 2005Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Aug 1, 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:361-72
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Perrin Luc, Ledergerber Bruno, Furrer Hansjakob, Swiss HIV Cohort Study
Is unsafe sexual behaviour increasing among HIV-infected individuals?
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Weber R, Rickenbach M, Vernazza P, Young J, Swiss HIV Cohort Study. Is unsafe sexual behaviour increasing among HIV-infected individuals?. AIDS (London, England) 2004; 18:1707-14.
Aug 20, 2004Is unsafe sexual behaviour increasing among HIV-infected individuals?
Aug 20, 2004AIDS (London, England) 2004; 18:1707-14
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Weber Rainer, Rickenbach Martin, Vernazza Pietro, Young Jim, Swiss HIV Cohort Study
Gynecomastia and potent antiretroviral therapy
Strub C, Kaufmann G, Flepp M, Egger M, Kahlert C, Cavassini M, Battegay M. Gynecomastia and potent antiretroviral therapy. AIDS (London, England) 2004; 18:1347-9.
Jun 18, 2004Gynecomastia and potent antiretroviral therapy
Jun 18, 2004AIDS (London, England) 2004; 18:1347-9
Strub Christoph, Kaufmann Gilbert R, Flepp Markus, Egger Martin, Kahlert Christian, Cavassini Matthias, Battegay Manuel
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Cavassini M, Furrer H, Perrin L, Weber R, Khanna N, Swiss HIV Cohort Study. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection. Antiviral therapy 2004; 9:263-74.
Apr 1, 2004Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Apr 1, 2004Antiviral therapy 2004; 9:263-74
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Cavassini Matthias, Furrer Hansjakob, Perrin Luc, Weber Rainer, Khanna Nina, Swiss HIV Cohort Study